EXPONENT INC (EXPO) Fundamental Analysis & Valuation

NASDAQ:EXPOUS30214U1025

Current stock price

66.56 USD
+1.53 (+2.35%)
At close:
66.56 USD
0 (0%)
After Hours:

This EXPO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. EXPO Profitability Analysis

1.1 Basic Checks

  • EXPO had positive earnings in the past year.
  • EXPO had a positive operating cash flow in the past year.
  • Each year in the past 5 years EXPO has been profitable.
  • Each year in the past 5 years EXPO had a positive operating cash flow.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

1.2 Ratios

  • EXPO's Return On Assets of 13.63% is amongst the best of the industry. EXPO outperforms 89.53% of its industry peers.
  • Looking at the Return On Equity, with a value of 27.16%, EXPO belongs to the top of the industry, outperforming 81.40% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 14.58%, EXPO is doing good in the industry, outperforming 75.58% of the companies in the same industry.
  • EXPO had an Average Return On Invested Capital over the past 3 years of 15.18%. This is above the industry average of 13.11%.
Industry RankSector Rank
ROA 13.63%
ROE 27.16%
ROIC 14.58%
ROA(3y)14.39%
ROA(5y)15.08%
ROE(3y)27.07%
ROE(5y)27.48%
ROIC(3y)15.18%
ROIC(5y)16.91%
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • EXPO's Profit Margin of 18.21% is amongst the best of the industry. EXPO outperforms 84.88% of its industry peers.
  • In the last couple of years the Profit Margin of EXPO has declined.
  • Looking at the Operating Margin, with a value of 20.58%, EXPO belongs to the top of the industry, outperforming 84.88% of the companies in the same industry.
  • EXPO's Operating Margin has been stable in the last couple of years.
  • EXPO has a better Gross Margin (92.22%) than 98.84% of its industry peers.
  • EXPO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.58%
PM (TTM) 18.21%
GM 92.22%
OM growth 3Y-9.14%
OM growth 5Y-0.23%
PM growth 3Y-2.97%
PM growth 5Y-2.47%
GM growth 3Y0.68%
GM growth 5Y-0.51%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

10

2. EXPO Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EXPO is still creating some value.
  • Compared to 1 year ago, EXPO has less shares outstanding
  • EXPO has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • EXPO has an Altman-Z score of 7.93. This indicates that EXPO is financially healthy and has little risk of bankruptcy at the moment.
  • EXPO has a better Altman-Z score (7.93) than 90.70% of its industry peers.
  • EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.93
ROIC/WACC1.62
WACC8.99%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.40 indicates that EXPO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.40, EXPO belongs to the top of the industry, outperforming 80.23% of the companies in the same industry.
  • A Quick Ratio of 2.40 indicates that EXPO has no problem at all paying its short term obligations.
  • EXPO has a better Quick ratio (2.40) than 80.23% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 2.4
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. EXPO Growth Analysis

3.1 Past

  • The earnings per share for EXPO have decreased by -1.89% in the last year.
  • Measured over the past 5 years, EXPO shows a small growth in Earnings Per Share. The EPS has been growing by 6.06% on average per year.
  • The Revenue has been growing slightly by 4.21% in the past year.
  • The Revenue has been growing slightly by 7.79% on average over the past years.
EPS 1Y (TTM)-1.89%
EPS 3Y2%
EPS 5Y6.06%
EPS Q2Q%6.52%
Revenue 1Y (TTM)4.21%
Revenue growth 3Y4.28%
Revenue growth 5Y7.79%
Sales Q2Q%4.54%

3.2 Future

  • EXPO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.40% yearly.
  • The Revenue is expected to grow by 7.39% on average over the next years.
EPS Next Y11.32%
EPS Next 2Y11.05%
EPS Next 3Y9.4%
EPS Next 5YN/A
Revenue Next Year10.8%
Revenue Next 2Y9.64%
Revenue Next 3Y7.39%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

1

4. EXPO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 32.00, EXPO can be considered very expensive at the moment.
  • 60.47% of the companies in the same industry are cheaper than EXPO, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.17, EXPO is valued a bit more expensive.
  • Based on the Price/Forward Earnings ratio of 28.75, the valuation of EXPO can be described as expensive.
  • Based on the Price/Forward Earnings ratio, EXPO is valued a bit more expensive than 60.47% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.05. EXPO is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 32
Fwd PE 28.75
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than 66.28% of the companies in the same industry.
  • EXPO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 26.79
EV/EBITDA 23.53
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of EXPO may justify a higher PE ratio.
PEG (NY)2.83
PEG (5Y)5.28
EPS Next 2Y11.05%
EPS Next 3Y9.4%

6

5. EXPO Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.92%, EXPO has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.86, EXPO pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, EXPO has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

  • The dividend of EXPO is nicely growing with an annual growth rate of 23.60%!
  • EXPO has paid a dividend for at least 10 years, which is a reliable track record.
  • EXPO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)23.6%
Div Incr Years12
Div Non Decr Years12
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • EXPO pays out 58.05% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of EXPO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP58.05%
EPS Next 2Y11.05%
EPS Next 3Y9.4%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

EXPO Fundamentals: All Metrics, Ratios and Statistics

EXPONENT INC

NASDAQ:EXPO (4/2/2026, 8:21:45 PM)

After market: 66.56 0 (0%)

66.56

+1.53 (+2.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners96.85%
Inst Owner Change0%
Ins Owners0.98%
Ins Owner Change4.17%
Market Cap3.28B
Revenue(TTM)582.01M
Net Income(TTM)106.01M
Analysts82
Price Target89.25 (34.09%)
Short Float %5.92%
Short Ratio5.77
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend1.23
Dividend Growth(5Y)23.6%
DP58.05%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-06
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.05%
Min EPS beat(2)1.67%
Max EPS beat(2)6.42%
EPS beat(4)4
Avg EPS beat(4)4.41%
Min EPS beat(4)1.67%
Max EPS beat(4)6.42%
EPS beat(8)8
Avg EPS beat(8)8.32%
EPS beat(12)8
Avg EPS beat(12)4.14%
EPS beat(16)12
Avg EPS beat(16)5.28%
Revenue beat(2)1
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)2.1%
Revenue beat(4)2
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.45%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.34%
EPS NQ rev (1m)-1.73%
EPS NQ rev (3m)3.81%
EPS NY rev (1m)0%
EPS NY rev (3m)1.79%
Revenue NQ rev (1m)0.66%
Revenue NQ rev (3m)5.92%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)2.69%
Valuation
Industry RankSector Rank
PE 32
Fwd PE 28.75
P/S 5.63
P/FCF 26.79
P/OCF 24.88
P/B 8.4
P/tB 8.59
EV/EBITDA 23.53
EPS(TTM)2.08
EY3.13%
EPS(NY)2.32
Fwd EY3.48%
FCF(TTM)2.48
FCFY3.73%
OCF(TTM)2.67
OCFY4.02%
SpS11.82
BVpS7.93
TBVpS7.75
PEG (NY)2.83
PEG (5Y)5.28
Graham Number19.26
Profitability
Industry RankSector Rank
ROA 13.63%
ROE 27.16%
ROCE 19.98%
ROIC 14.58%
ROICexc 23.15%
ROICexgc 23.69%
OM 20.58%
PM (TTM) 18.21%
GM 92.22%
FCFM 21.02%
ROA(3y)14.39%
ROA(5y)15.08%
ROE(3y)27.07%
ROE(5y)27.48%
ROIC(3y)15.18%
ROIC(5y)16.91%
ROICexc(3y)25%
ROICexc(5y)29.54%
ROICexgc(3y)25.65%
ROICexgc(5y)30.45%
ROCE(3y)20.8%
ROCE(5y)23.17%
ROICexgc growth 3Y-15.95%
ROICexgc growth 5Y-3.77%
ROICexc growth 3Y-15.68%
ROICexc growth 5Y-3.44%
OM growth 3Y-9.14%
OM growth 5Y-0.23%
PM growth 3Y-2.97%
PM growth 5Y-2.47%
GM growth 3Y0.68%
GM growth 5Y-0.51%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 93.13%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 101.43%
Profit Quality 115.41%
Current Ratio 2.4
Quick Ratio 2.4
Altman-Z 7.93
F-Score6
WACC8.99%
ROIC/WACC1.62
Cap/Depr(3y)116.06%
Cap/Depr(5y)124.71%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.94%
Profit Quality(3y)117.42%
Profit Quality(5y)109.7%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.89%
EPS 3Y2%
EPS 5Y6.06%
EPS Q2Q%6.52%
EPS Next Y11.32%
EPS Next 2Y11.05%
EPS Next 3Y9.4%
EPS Next 5YN/A
Revenue 1Y (TTM)4.21%
Revenue growth 3Y4.28%
Revenue growth 5Y7.79%
Sales Q2Q%4.54%
Revenue Next Year10.8%
Revenue Next 2Y9.64%
Revenue Next 3Y7.39%
Revenue Next 5YN/A
EBIT growth 1Y0.19%
EBIT growth 3Y-5.25%
EBIT growth 5Y7.55%
EBIT Next Year43.95%
EBIT Next 3Y16.08%
EBIT Next 5YN/A
FCF growth 1Y-11.09%
FCF growth 3Y14.38%
FCF growth 5Y4.47%
OCF growth 1Y-8.86%
OCF growth 3Y11.98%
OCF growth 5Y4.98%

EXPONENT INC / EXPO Fundamental Analysis FAQ

What is the fundamental rating for EXPO stock?

ChartMill assigns a fundamental rating of 7 / 10 to EXPO.


What is the valuation status of EXPONENT INC (EXPO) stock?

ChartMill assigns a valuation rating of 2 / 10 to EXPONENT INC (EXPO). This can be considered as Overvalued.


What is the profitability of EXPO stock?

EXPONENT INC (EXPO) has a profitability rating of 8 / 10.


What is the financial health of EXPONENT INC (EXPO) stock?

The financial health rating of EXPONENT INC (EXPO) is 10 / 10.


Is the dividend of EXPONENT INC sustainable?

The dividend rating of EXPONENT INC (EXPO) is 6 / 10 and the dividend payout ratio is 58.05%.